Results 191 to 200 of about 243,296 (232)
, 1974 Some of the next articles are maybe not open access.
Related searches:
Related searches:
Analytical Chemistry, 2010
Room temperature rate constants and product ion branching ratios have been measured for the reactions of numerous positive and negative ions with VX chemical warfare agent surrogates representing the amine (triethylamine) and organophosphonate (diethyl methythiomethylphosphonate (DEMTMP)) portions of VX.
Anthony J, Midey +5 more
openaire +2 more sources
Room temperature rate constants and product ion branching ratios have been measured for the reactions of numerous positive and negative ions with VX chemical warfare agent surrogates representing the amine (triethylamine) and organophosphonate (diethyl methythiomethylphosphonate (DEMTMP)) portions of VX.
Anthony J, Midey +5 more
openaire +2 more sources
Analysis of Trace VX in Acidified VX Hydrolysate Samples
2009Abstract : The objective of this study was to modify and optimize US Army Element, Assembled Chemical Weapons Alternatives (USAE ACWA) method BGCAPP-204 (VX in Caustic Hydrolysate by Cool on-Column GC/MS) for analysis of ethyl S-2-diisopropylaminoethyl methylphosphonothiolate (VX) in acidified VX hydrolysate matrices.
Yu-Chu Yang, Dennis K. Rohrbaugh
openaire +1 more source
Notfall & Rettungsmedizin, 2002
Lange Zeit war ein chemischer Kampfmittelangriff ein militarisches Szenario. Spatestens seit der Attacke mit Sarin auf die Tokioter U-Bahn im Jahre 1995 durch den Aum-Shinrikyo-Kult werden zivile Kampfstoffeinsatze in den Szenarien von vielen Katastrophenplanern mit einbezogen.
T. Bey, F. G. Walter
openaire +1 more source
Lange Zeit war ein chemischer Kampfmittelangriff ein militarisches Szenario. Spatestens seit der Attacke mit Sarin auf die Tokioter U-Bahn im Jahre 1995 durch den Aum-Shinrikyo-Kult werden zivile Kampfstoffeinsatze in den Szenarien von vielen Katastrophenplanern mit einbezogen.
T. Bey, F. G. Walter
openaire +1 more source
Chemical & Engineering News Archive, 2005
THE ARMY'S CONTROVERSIAL and problem-plagued plan to destroy VX nerve agent stored at Newport, Ind., just hit another snag: The waste by-product of VX neutralization is flammable. Under current plans, the Army would neutralize VX at Newport and transport the by-product, called hydrolysate, to a DuPont facility in New Jersey for secondary treatment and ...
openaire +1 more source
THE ARMY'S CONTROVERSIAL and problem-plagued plan to destroy VX nerve agent stored at Newport, Ind., just hit another snag: The waste by-product of VX neutralization is flammable. Under current plans, the Army would neutralize VX at Newport and transport the by-product, called hydrolysate, to a DuPont facility in New Jersey for secondary treatment and ...
openaire +1 more source
Main Group Chemistry, 2010
O-ethyl S-(2-diisopropylaminoethyl)phosphonothiolate (VX) is among the most toxic of chemical warfare agents. VX is an oily liquid that is relatively involatile and is slow to hydrolyze, and thus may persist for weeks or longer in the environment, creating long term contamination of the territory.
openaire +1 more source
O-ethyl S-(2-diisopropylaminoethyl)phosphonothiolate (VX) is among the most toxic of chemical warfare agents. VX is an oily liquid that is relatively involatile and is slow to hydrolyze, and thus may persist for weeks or longer in the environment, creating long term contamination of the territory.
openaire +1 more source
State-Dependent Inhibition of Nav1.8 Sodium Channels by VX-150 and VX-548
Molecular PharmacologyNav1.8 sodium channels (Nav1.8) are an attractive therapeutic target for pain because they are prominent in primary pain-sensing neurons with little expression in most other kinds of neurons. Recently, two Nav1.8-targeted compounds, VX-150 and VX-548, have shown efficacy in clinical trials for reducing pain.
Patric Vaelli +6 more
openaire +2 more sources
Current opinion in investigational drugs (London, England : 2000), 2005
Vertex and Mitsubishi are developing VX-950 (LY-570310), the lead compound from a program of small-molecule inhibitors of the hepatitis C virus (HCV) NS3 protease, for the potential treatment of HCV infection. In November 2004, Vertex initiated a phase Ib European trial of VX-950 for the treatment of HCV infection.
openaire +2 more sources
Vertex and Mitsubishi are developing VX-950 (LY-570310), the lead compound from a program of small-molecule inhibitors of the hepatitis C virus (HCV) NS3 protease, for the potential treatment of HCV infection. In November 2004, Vertex initiated a phase Ib European trial of VX-950 for the treatment of HCV infection.
openaire +2 more sources